ACCRETION PHARMA LIMITED Peer Comparison
ACCPL · Healthcare · Current price ₹165.65
Peers tracked
11
ACCRETION PHARMA LIMITED P/E
19.9x
Sector
Healthcare
ACCRETION PHARMA LIMITED vs peers
| Company | Price | P/E | Market cap (Cr) |
|---|---|---|---|
| SUN PHARMACEUTICAL IND L | ₹1,932.6 | 39.1x | 4,63,789 |
| DIVI S LABORATORIES LTD | ₹7,247.5 | 69.1x | 1,92,406 |
| TORRENT PHARMACEUTICALS L | ₹4,763 | 72.9x | 1,61,243 |
| ZYDUS LIFESCIENCES LTD | ₹1,143.7 | 22.0x | 1,15,087 |
| CIPLA LTD | ₹1,418.7 | 30.3x | 1,14,589 |
| LUPIN LIMITED | ₹2,443.2 | 20.6x | 1,11,704 |
| MANKIND PHARMA LIMITED | ₹2,484.2 | 53.7x | 1,02,569 |
| DR. REDDY S LABORATORIES | ₹1,211.2 | 26.8x | 1,01,090 |
| AUROBINDO PHARMA LTD | ₹1,533.4 | 25.9x | 89,061 |
| LAURUS LABS LIMITED | ₹1,529.8 | 92.8x | 82,511 |
| ACCRETION PHARMA LIMITED | ₹165.65 | 18.5x | 0 |
ACCRETION PHARMA LIMITED versus its peers
ACCRETION PHARMA LIMITED operates in the Healthcare space alongside 11 tracked peers. Comparing valuation multiples within a sector is far more meaningful than in isolation — a P/E of 19.9x may be cheap in one industry and expensive in another.
More on ACCRETION PHARMA LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.